Elka Nir is listed as a director on 4 SEC Form D filings by 2 issuers between Sep 2013 and Oct 2025: IceCure Medical Ltd. (Caesarea, Israel (as filed: L3) — biotechnology — 2013; $16.5M reported sold to 16 investors) and TRENDLINES GROUP LTD. (M.P. Misgav, Israel (as filed: L3) — other health care — 2022–2025; $15M reported sold to 19 investors).
What this means 2 separate companies raised money with this person listed as director, over about 12 years. Across those companies the filings report $31.5M sold in total.
Listed alongside Boon Ann Sin (3 shared filings), Haim Brosh (3 shared filings), Low Teck Seng (2 shared filings), Nehama Ronen (2 shared filings), Sarit Zeevi (2 shared filings) and 17 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Elka. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 4 public filings for Elka Nir and found 1 difference: No amendment in the last 12 months on an offering that may still be open.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.